General Updates

Sun Pharmaceutical Industries Limited Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai – 400 063, Maharashtra, INDIA. Tel. : (91-22) 4324 4324 Fax : (91-22) 4324 4343 Website: www.sunpharma.com Email: secretarial@sunpharma.com CIN: L24230GJ1993PLC019050 31 July 2026 National Stock Exchange of India Limited BSE Limited Scrip Symbol: SUNPHARMA Scrip Code: 524715 Voting Results and Scrutinizer Report of 34th AGM held on 31 July 2026 This is to inform that the 34th Annual General Meeting (“AGM”) of the Company was held and concluded on 31 July 2026. Pursuant thereto, the Scrutinizer has submitted his report to the Company. Based on the Scrutinizer’s Report, all resolutions specified in the Notice of the 34th AGM dated 06 July 2026 have been passed by the shareholders with the requisite majority. The resolutions shall be effective in accordance with the applicable provisions of law. The Voting Results have been submitted by the Company and the Scrutinizer Report is made available on the Company’s website at www.sunpharma.com. For Sun Pharmaceutical Industries Limited (Anoop Deshpande) Company Secretary and Compliance Officer ICSI Membership No.: A23983 Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA. Reaching People. Touching Lives.